Note: Lancet requires free registration prior to providing access. “Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial,” by Susan O’Brien, Richard R. Furman, Steven E. Coutre, Jeff P. Sharman, Jan A. Burger, Kristie A. Blum, Barbara Grant, Donald A. Richards, Morton Coleman, William G. Wierda, Jeffrey A. Jones, Weiqiang Zhao, Nyla A. Heerema, Amy J. Johnson, Raquel Izumi, Ahmed Hamdy, Betty Y. Chang, Thorsten Graef, Fong Clow, Joseph J. Buggy, Danelle F. James, and John C. Byrd (Vol. 15, No. 1, January 2014, p. 48-58).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70513-8/abstract
